Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

NCT07285265 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Varicella-zoster Virus

Interventions

BIOLOGICAL: ABO1108
DRUG: Placebo
BIOLOGICAL: SHINGRIX

Sponsor

Suzhou Abogen Biosciences Co., Ltd.

Collaborators

[object Object]